RAB42

RAB42, member RAS oncogene family Q8N4Z0 RAB42_HUMAN
Protein Coding Chr 1 1p35.3 Swiss-Prot reviewed Entrez 115273
Mutations
92
CL 28 · Tissue 64
Samples
62
CL 22 · Tissue 40
Peptides
50
unique mutant peptides
Transcripts
2
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations922864
Samples622240
Peptides501833

Function

RAB42 · RAB42, member RAS oncogene family

Predicted to enable GDP binding activity; GTP binding activity; and GTPase activity. Predicted to be involved in Ras protein signal transduction. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Isoforms & Proteins

2 transcripts · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000465518 Q8N4Z0 63 47
ENST00000373826 Q8N4Z0-1 29 25

Gene Properties

Type
Protein Coding
Chromosome
1
Cytoband
1p35.3
Entrez ID

Recurrent Mutations

All 47 amino-acid changes on canonical ENST00000465518 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in RAB42 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in RAB42 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
T-Lymphoblastic Leukemia
3/40 8%
0/0 0%
Acute Myeloid Leukemia
1/90 1%
0/0 0%
Endometrial Carcinoma
1/42 2%
3/612 0%
Osteosarcoma
1/45 2%
0/166 0%
Colorectal Carcinoma
7/143 5%
6/3239 0%
Other Sarcomas
2/69 3%
0/699 0%
Squamous Cell Lung Carcinoma
0/57 0%
2/810 0%
Esophageal Squamous Cell Carcinoma
0/51 0%
6/2550 0%
Hepatocellular Carcinoma
0/46 0%
5/2210 0%
Bladder Carcinoma
0/58 0%
2/956 0%
Pancreatic Carcinoma
0/89 0%
3/1611 0%
Gastric Carcinoma
0/74 0%
3/1809 0%
Melanoma
1/210 0%
2/1899 0%
Small Cell Lung Carcinoma
0/9 0%
1/752 0%
Breast Carcinoma
3/144 2%
1/3264 0%
Non-Cancerous
1/104 1%
0/830 0%
Ovarian Carcinoma
0/109 0%
1/998 0%
Glioma
2/52 4%
0/2127 0%
Other Solid Cancers
0/94 0%
1/1515 0%
Head and Neck Carcinoma
0/85 0%
1/1574 0%
Non-Small Cell Lung Carcinoma
0/304 0%
1/1390 0%
Kidney Carcinoma
0/85 0%
1/1862 0%
Prostate Carcinoma
0/13 0%
1/2105 0%

Mutation Distribution

Where RAB42 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in RAB42 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 54 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 92 mutations in RAB42

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide